These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7897409)

  • 1. Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology?
    Ben-Shlomo Y; Marmot MG
    J Neurol Neurosurg Psychiatry; 1995 Mar; 58(3):293-9. PubMed ID: 7897409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does levodopa therapy delay death in Parkinson's disease? A review of the evidence.
    Clarke CE
    Mov Disord; 1995 May; 10(3):250-6. PubMed ID: 7651439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and quality of death certification in a cohort of patients with Parkinson's disease and matched controls in North Wales, UK at 18 years: a community-based cohort study.
    Hobson P; Meara J
    BMJ Open; 2018 Feb; 8(2):e018969. PubMed ID: 29444783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.
    Savica R; Grossardt BR; Bower JH; Ahlskog JE; Boeve BF; Graff-Radford J; Rocca WA; Mielke MM
    JAMA Neurol; 2017 Jul; 74(7):839-846. PubMed ID: 28505261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parkinson disease survival: a population-based study.
    Morgante L; Salemi G; Meneghini F; Di Rosa AE; Epifanio A; Grigoletto F; Ragonese P; Patti F; Reggio A; Di Perri R; Savettieri G
    Arch Neurol; 2000 Apr; 57(4):507-12. PubMed ID: 10768625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential inquiry.
    Ben-Shlomo Y; Churchyard A; Head J; Hurwitz B; Overstall P; Ockelford J; Lees AJ
    BMJ; 1998 Apr; 316(7139):1191-6. PubMed ID: 9583926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort.
    Marras C; McDermott MP; Rochon PA; Tanner CM; Naglie G; Rudolph A; Lang AE;
    Neurology; 2005 Jan; 64(1):87-93. PubMed ID: 15642909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid function and mortality in patients treated for hyperthyroidism.
    Franklyn JA; Sheppard MC; Maisonneuve P
    JAMA; 2005 Jul; 294(1):71-80. PubMed ID: 15998893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom.
    Lees AJ
    BMJ; 1995 Dec; 311(7020):1602-7. PubMed ID: 8555803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Parkinson's disease.
    Rajput AH
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):156-9. PubMed ID: 6713314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality from Parkinson's disease in England and Wales 1921-89.
    Clarke CE
    J Neurol Neurosurg Psychiatry; 1993 Jun; 56(6):690-3. PubMed ID: 8509785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study.
    Driver JA; Kurth T; Buring JE; Gaziano JM; Logroscino G
    Neurology; 2008 Apr; 70(16 Pt 2):1423-30. PubMed ID: 18413567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of selegiline on mortality in patients with Parkinson's disease: a meta-analysis.
    Olanow CW; Myllylä VV; Sotaniemi KA; Larsen JP; Pålhagen S; Przuntek H; Heinonen EH; Kilkku O; Lammintausta R; Mäki-Ikola O; Rinne UK
    Neurology; 1998 Sep; 51(3):825-30. PubMed ID: 9748034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease patients first treated at age 75 years or older: a comparative study.
    Peretz C; Chillag-Talmor O; Linn S; Gurevich T; El-Ad B; Silverman B; Friedman N; Giladi N
    Parkinsonism Relat Disord; 2014 Jan; 20(1):69-74. PubMed ID: 24183677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.
    Weintraub D; Chiang C; Kim HM; Wilkinson J; Marras C; Stanislawski B; Mamikonyan E; Kales HC
    JAMA Neurol; 2016 May; 73(5):535-41. PubMed ID: 26999262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levodopa in Parkinson disease: a long-term appraisal of mortality.
    Joseph C; Chassan JB; Koch ML
    Ann Neurol; 1978 Feb; 3(2):116-8. PubMed ID: 418738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The natural history of Parkinson's disease in the province of Segovia: mortality in a longitudinal study (20-year follow-up).
    Duarte J; García Olmos LM; Mendoza A; Clavería LE
    Acta Neurol Scand; 2013 May; 127(5):295-300. PubMed ID: 22957805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical course of patients with idiopathic Parkinson's disease.
    Roos RA; Jongen JC; van der Velde EA
    Mov Disord; 1996 May; 11(3):236-42. PubMed ID: 8723138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levodopa therapy and survival in idiopathic Parkinson's disease: Olmsted County project.
    Uitti RJ; Ahlskog JE; Maraganore DM; Muenter MD; Atkinson EJ; Cha RH; O'Brien PC
    Neurology; 1993 Oct; 43(10):1918-26. PubMed ID: 8413948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality associated with early and late levodopa therapy initiation in Parkinson's disease.
    Scigliano G; Musicco M; Soliveri P; Piccolo I; Girotti F; Giovannini P; Caraceni T
    Neurology; 1990 Feb; 40(2):265-9. PubMed ID: 2300246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.